ArticleiScience2024

Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.

Javier García-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.